- STAT+: FDA staff and peptide enthusiasts set to clash at advisory panelFDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer bet than the gray-market versions now in use.STAT · 1d ago↗ source
- STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explainsIn this edition of AI Prognosis, Brittany Trang talks to Alex LeBrun, AI scribe company Nabla's executive chairman, about an alternative to LLMsSTAT · 1d ago↗ source
- New study supports testing of Merck’s Ebola vaccine in DRC outbreakNew data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.STAT